Cheryl Walker Selected Research

Fatigue

12/2010

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheryl Walker Research Topics

Disease

5	Neoplasms (Cancer) 10/2021 - 09/2002
2	Autistic Disorder (Autism) 07/2011 - 01/2010
2	Leiomyoma (Uterine Fibroids) 03/2010 - 01/2009
1	Dysbiosis 10/2021
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Genomic Instability 01/2020
1	Fever (Fevers) 01/2013
1	Anemia 12/2010
1	Fatigue 12/2010
1	Lymphopenia (Lymphocytopenia) 12/2010
1	Nausea 12/2010
1	Pain (Aches) 12/2010
1	Endometrial Neoplasms (Endometrial Cancer) 12/2010
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 03/2010
1	Angiomyolipoma 03/2010
1	Developmental Disabilities (Developmental Disability) 01/2003

Drug/Important Bio-Agent (IBA)

1	2,2',4,4',5-brominated diphenyl etherIBA 10/2021
1	ChromatinIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Histones (Histone)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 04/2013
1	AntipyreticsIBA 01/2013
1	ORALIT (ORS)IBA 07/2011
1	TensinsIBA 12/2010
1	Pharmaceutical PreparationsIBA 12/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2010
1	TOR Serine-Threonine KinasesIBA 12/2010
1	Everolimus FDA Link 12/2010
1	trans-sodium crocetinate (crocetin)IBA 03/2010
1	lipoarabinomannan (LAM)IBA 03/2010
1	MercuryIBA 01/2010
1	Dihydrotachysterol (AT 10)IBA 01/2009
1	Thymidine KinaseIBA 01/2009
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2009
1	Substance PIBA 01/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2003
1	salicylhydroxamic acid (SHAM)IBA 09/2002

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2009
1	Analgesia 01/2003